Late-Stage Pipeline Advancements and Novel Therapies Position Sector for Accelerated Growth and Major Value CatalystsMarket News Updates News ...

In this role, Dr. Lewis-Hall will guide clinical development strategy, regulatory engagement, and translational rigor across ...

SpringWorks Therapeutics, a subsidiary of German drugmaker Merck KGaA, today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for ...

Health care is firmly in a new era of innovation, driven by ongoing advancements across biotech, life science tools and diagnostics, and managed care and distributors. These developments are steadily ...

LONDON, Feb 13 (Reuters) - Sanofi's incoming CEO, 65-year-old Belén Garijo, faces a major ⁠task ⁠to win over investors, accelerate the French company's stalled drug ⁠development pipeline and navigate ...

Feb 12 (Reuters) - French drugmaker Sanofi on Thursday appointed Belén Garijo as its new chief executive after choosing not ...

French drugmaker Sanofi on Thursday appointed Belén Garijo as its new chief executive after choosing not to renew the mandate of Paul Hudson.

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.

STAMFORD, Conn. (AP) — STAMFORD, Conn. (AP) — SpringWorks Therapeutics Inc. (SWTX) on Friday reported a loss of $83.2 million in its first quarter. The Stamford, Connecticut-based company said it had ...

The Ademi Firm is investigating SpringWorks (Nasdaq: SWTX) for possible breaches of fiduciary duty and other violations of law in its transaction with Merck. Click here to learn how to join our ...